Der Internist

, Volume 52, Issue 7, pp 902–903 | Cite as

Monoklonale Antikörper für die Therapie des metastasierten Melanoms

Klinische Studien

Monoclonal antibody in the therapy of metastatic melanoma

Literatur

  1. 1.
    Hersh EM, O’Day SJ, Powderly J et al (2010) A phase II multicenter study of ipilimumb with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. Invest New Drugs [Epub ahead of print]Google Scholar
  2. 2.
    Hodi FS, Steven J, O’Day SJ et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723PubMedCrossRefGoogle Scholar
  3. 3.
    Lawrence D, Hamid O, McDermott D et al (2010) Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastasis. ASCO Annual Meeting 2010, Abstract 8523Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Dermatologie und Allergologie am BiedersteinKlinikum rechts der Isar, TU MünchenMünchenDeutschland
  2. 2.Werl-WestönnenDeutschland

Personalised recommendations